Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

TE Hickey, JLL Robinson, JS Carroll… - Molecular …, 2012 - academic.oup.com
Androgen receptor (AR) signaling exerts an antiestrogenic, growth-inhibitory influence in
normal breast tissue, and this role may be sustained in estrogen receptor α (ERα)-positive …

Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research

HK Neilson, CM Friedenreich, NT Brockton… - … Biomarkers & Prevention, 2009 - AACR
Convincing evidence now supports a probable preventive role for physical activity in
postmenopausal breast cancer. The mechanisms by which long-term physical activity affect …

The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines

K Subik, JF Lee, L Baxter, T Strzepek… - Breast cancer: basic …, 2010 - journals.sagepub.com
The molecular classification for breast carcinomas has been used in clinical studies with a
simple surrogate panel of immunohistochemistry (IHC) markers. The objective of this current …

Identification of molecular apocrine breast tumours by microarray analysis

P Farmer, H Bonnefoi, V Becette… - Breast Cancer …, 2005 - Springer
S2 cancer in the general population remains unclear. Furthermore, the methodology of ATM
mutation detection is still laborious and costly. Because the ATM protein kinase …

[HTML][HTML] Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

LC Collins, KS Cole, JD Marotti, R Hu, SJ Schnitt… - Modern Pathology, 2011 - Elsevier
Previous studies have demonstrated that androgen receptor is expressed in many breast
cancers, but its expression in relation to the various breast cancer subtypes as defined by …

[HTML][HTML] Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

LA Niemeier, DJ Dabbs, S Beriwal, JM Striebel… - Modern Pathology, 2010 - Elsevier
Androgens exert growth inhibitory effects on estrogen receptor and progesterone receptor-
negative breast cancer cell lines that show androgen receptor expression. These laboratory …

[HTML][HTML] Expression of androgen receptors in primary breast cancer

S Park, J Koo, HS Park, JH Kim, SY Choi, JH Lee… - Annals of oncology, 2010 - Elsevier
Background To investigate the clinicopathological significance of androgen receptor (AR)
expression in primary breast cancers. Patients and methods We evaluated AR using …

[HTML][HTML] Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers

S Park, JS Koo, MS Kim, HS Park, JS Lee, SI Kim… - Annals of …, 2011 - Elsevier
Background The objective of the study was to evaluate the implications of androgen receptor
(AR) in breast cancers. Patients and methods We investigated immunohistochemical AR …

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

S Loibl, BM Müller, G von Minckwitz… - Breast cancer research …, 2011 - Springer
The androgen receptor (AR) has been shown to be of potential prognostic importance in
retrospective cohorts. We evaluated immunohistochemical AR expression on a tissue …

[HTML][HTML] Role of the androgen receptor in triple-negative breast cancer

M Rampurwala, KB Wisinski… - Clinical advances in …, 2016 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) is an aggressive disease with outcomes inferior to
those of other breast cancer subtypes. No targeted therapies are currently approved for …